LRRK2 as a therapeutic target in Parkinson's disease
10.1111/j.1468-1331.2010.03305.x
Saved in:
Main Authors: | Tan, E.K., Schapira, A.H. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Editorial |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110671 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
New LRRK2 variants identified in Parkinson's disease
by: Tan, E.K., et al.
Published: (2014) -
Targeting LRRK2 in Parkinson's disease: an update on recent developments
by: Chan S.L., et al.
Published: (2018) -
LRRK2 mutations are not frequent in Swiss patients with Parkinson's disease
by: Burgunder, J.-M., et al.
Published: (2011) -
LRRK2 in Parkinson's disease: Genetic and clinical studies from patients
by: Kumari U., et al.
Published: (2018) -
Summary of GIGYF2 studies in Parkinson's disease: The burden of proof
by: Tan, E.K., et al.
Published: (2014)